December 2006 Archives

A stocky woman in blue jeans with spiky, gelled black hair dances on stage at one of Vietnam's rural rehabilitation centres, leading a hip-hop style chant.

"Hold hands together, we'll stop AIDS together," shouted the former heroin addict patient who returned to the rehabilitation centre to encourage over a thousand recovering drug users and prostitute inmates, a third of whom have HIV or AIDS.

People face stigma and discrimination when they leave the minimum security centres, especially if they are infected with HIV or have AIDS. HIV-infected people are often refused employment and their children denied schooling.

"Everybody should unite in combating this disease," said Danh Thu Hanh, 36, a former addict who spent two years as an inmate.

The British Embassy in Dublin has announced that U2 frontman Bono is being awarded an honorary knighthood by the Queen.

The singer, whose real name is Paul Hewson, has been given the honour for "his services to the music industry and for his humanitarian work," it said.

Prime Minister Tony Blair congratulated him, telling the singer in a letter: "You have tirelessly used your voice to speak up for Africa."

Bono will receive the honour in Dublin early in the new year, and British ambassador David Reddaway will conduct the ceremony.

WEDNESDAY, Dec. 27 (HealthDay News) -- Surgical patients with HIV, the virus that causes AIDS, are more likely to develop pneumonia after their operation and to die within one year compared to uninfected patients, U.S. researchers report.

The study also found that HIV patients with a preoperative viral load (number of copies of virus in the blood) greater than 30,000 per milliliter appeared to be most likely to suffer surgical complications.

In the study, a team from Kaiser Permanente Medical Care Program-Northern California, in Oakland, analyzed surgical outcomes for 332 HIV patients who had a number of different kinds of operations (including heart, abdominal and orthopedic) between 1997 and 2002. They compared those outcomes to outcomes for 332 surgical patients without HIV.

More HIV patients developed pneumonia after surgery (2.4 percent vs. 0.3 percent), and more HIV patients died within 12 months after their surgery (3 percent vs. 0.6 percent).

APIWAT KWANGKAEW can still remember the day, nearly five years ago, when Thailand began producing nevirapine, a generic anti-retroviral drug. Within an hour of the announcement, hospital wards across the country were backed up with patients.

These were people who knew they were sick but could not afford treatment. With a population of 64 million, Thailand has more than 1 million people living with HIV/AIDS. Some believe the figure is much higher.

The drug helped save Mr Apiwat's life. Now he is fighting to save others, taking on the US pharmaceutical giant Merck for the right to break the patent on the anti-retroviral drug efavirenz, and produce another generic HIV-AIDS treatment.

CHATTANOOGA, Tenn. In the 25 years since the U-S Centers for Disease Control and Prevention identified AIDS, misconceptions still surround the disease in Tennessee.

Many people still associate H-I-V and AIDS with gay white men, but in Hamilton County last year, 51 percent of all reported cases of H-I-V were blacks.

Increasingly, AIDS sufferers also include Hispanics, women and children.Meantime, misconceptions persist about how someone can become infected with H-I-V.

Some youngsters still think you can get H-I-V from mosquitoes or from sitting on a toilet seat.

Copyright 2006 Associated Press

A yearlong effort by New York City’s health commissioner to do away with a state requirement that patients give their written consent before being tested for H.I.V. has created a sharp rift among doctors and advocates for people with H.I.V. and AIDS.

More than 1,400 people in the city died from AIDS-related illnesses last year. Of the more than 100,000 New Yorkers who are infected with H.I.V., the virus that causes AIDS, perhaps one-fifth do not know it, according to city estimates. About one-fourth of H.I.V. diagnoses are made when the patient already has AIDS, by which time the infection has gone undetected for a decade, on average.

Alarmed by those facts, the health commissioner, Dr. Thomas R. Frieden, co-wrote an article in The New England Journal of Medicine a year ago calling for governments to be much more aggressive in monitoring and caring for people with H.I.V., and to treat the virus more like other infectious diseases.

As news spreads around the world about a Libyan court’s decision to re-impose the death sentences on five Bulgarian nurses and one Palestinian doctor for supposedly deliberately infecting hundreds of children with HIV, world leaders are starting to express their disappointment, shock and horror.

George Bush communicated his “disappointment” to Georgi Parvanov, the Bulgarian President. Bush said he is fully behind Bulgaria’s attempts to strive for the release of the five nurses.

Condoleezza Rice, US Secretary of State said it is urgent that the medical workers are freed and allowed to go home as soon as possible. They have been in prison since 1999. Johannes Laitenberger, a spokesman for the European Union, said the EU will decide what steps to take against Libya after a legal appeal is launched and concluded.

Valeant Pharmaceuticals International (NYSE: VRX) announced the sale of certain of its discovery and preclinical assets to Ardea Biosciences, Inc. (formerly IntraBiotics Pharmaceuticals) (OTC: IBPI). The sale includes the rights to Valeant's HIV and cancer development programs.

Under the terms of the agreement, Ardea will make payments to Valeant upon the achievement of clinical milestones for both HIV and cancer programs. Valeant will retain an option, exercisable upon the completion of Phase 2b studies by Ardea, to reacquire rights to commercialize its HIV program outside of the United States and Canada upon Ardea's completion of Phase 3 trials. Ardea will pay Valeant development milestones and royalties upon its commercialization of the HIV and cancer programs. Valeant would make milestone and royalty payments to Ardea related to the clinical advancement and commercialization of the HIV program should Valeant exercise its option to this program.

source - StreetInsider 

St. Paul, Minn. — An AIDS research program at the University of Minnesota is being forced to close after 20 years of running clinical trials. The National Institutes of Health has cut back on domestic research funding for HIV/AIDS, but plans to perform clinical trials in developing nations.

The Minnesota ACTU is one of eight programs whose research grants have not been renewed by the NIH.

Hank Balfour is the principal investigator of the Minnesota ACTU and the University of Minnesota's International Center for Antiviral Research and Epidemiology. He says other public health concerns, like avian flu or bioterrorism, may be perceived to be greater threats.

source - Minnesota Public Radio

President Bush told Bulgarian President Georgi Parvanov on Thursday that he was disappointed with a Libyan court decision to reimpose the death sentences on Bulgarian nurses and a Palestinian doctor accused of infecting Libyan children with HIV.

Bush spoke with Parvanov on the phone from the White House about the Libyan decision, expressing his strong support for Bulgaria's efforts to secure the release of the medics, said Gordon Johndroe, a spokesman for the National Security Council.

The president also congratulated Parvanov on Bulgaria's accession as a member of the European Union, which will formally take place on Jan. 1.

Bulgaria's president, the chairman of the National Assembly and the country's prime minister sent an open letter to the heads of state and parliamentary heads of all EU member states in connection with the Libya HIV trial.

The letter was also sent to NATO, UN, the Council of Europe and the European Parliament.

The letter mentions Libyan court's negligence and its rejection to take into consideration the expertise and opinion of the world-acknowledged scientist in the area of HIV and AIDS.

President Georgi Parvanov expressed his gratitude to Bulgaria's partners and allies for their support of the just cause.

President George W. Bush signed the Ryan White HIV/AIDS Treatment Modernization Act of 2006 into law today, officially reauthorizing the Ryan White CARE Act until Sept 30, 2009. AIDS Action Council, a Washington non-profit organization that advocates on behalf of people living with HIV and AIDS and that helped to create and ensure passage of the original Ryan White CARE Act in 1990, expressed its thanks to the President and to Members of Congress who took action to pass the reauthorized CARE Act prior to the 109th Congress's final adjournment.

"We are pleased that the President and Congress engaged in a serious, bipartisan, bicameral effort. This bill will clearly serve many people living with HIV and AIDS in the United States," said Rebecca Haag, Executive Director, AIDS Action Council. "However, this bill alone is not sufficient to ensure that life saving drugs and medical treatment is available to all who are infected. Appropriations have fallen far short over the last several years while the epidemic is growing with 40,000 new infections every year. The reality is we need more funding. We urge the President to add additional funds to his budget request for next year and will work with the new Congress to make sure that additional resources are made available."

This fact sheet summarizes information in four areas of male circumcision:

1. male circumcision and risk of HIV transmission;
2. male circumcision and other health conditions;
3. risks associated with male circumcision; and
4. status of HIV infection and male circumcision in the United States.

What is Male Circumcision?

Male circumcision is the surgical removal of some or all of the foreskin (or prepuce) from the penis [2].

MONTREAL, QUEBEC -- December 19, 2006 -- Theratechnologies (TSX: TH) today announced positive top line results for its Phase 3 clinical trial, testing the Company's lead compound, TH9507, in patients with HIV-associated lipodystrophy, a serious medical condition common in HIV patients. The study was powered to detect an 8% reduction in visceral adipose tissue (VAT) versus placebo. After 26 weeks, patients on TH9507 achieved a 15% reduction in VAT versus baseline and a 20% difference versus placebo. Further, TH9507 was shown to be well tolerated by patients.

Yves Rosconi, President and Chief Executive Officer of Theratechnologies, stated, "We are very excited by the results that we are announcing today. These data add strong support to our clinical development plans for TH9507. The emerging efficacy/safety profile of TH9507 is exactly what we were hoping for. It has great prospects as a treatment for excess visceral fat accumulation in HIV patients, with potential advantages over other approaches being developed. The next step is to confirm these results through a second study. The preparations for the new study in North America and Europe are well advanced and we expect to enroll our first patients during the first quarter of 2007", Mr. Rosconi added.

Recent data by the Joint United Nations Programme on HIV and Aids (UNAids) on the decline of infections may have been inaccurate, a workshop was told.

It was noted that many Kenyans do not fight the scourge either due to religious reasons or cultural practices and beliefs.

The National Muslim Council of Women of Kenya (NMCWK) chairperson, Ms Nazlin Omar, said her organisation was training Muslim leaders on attitude change of the Muslim community.

A court convicted five Bulgarian nurses and a Palestinian doctor Tuesday of deliberately infecting 400 children with HIV and sentenced them to death, despite scientific evidence the youngsters had the virus before the medical workers came to Libya.

The United States and Europe reacted with outrage to the verdict, which prolongs a case that has hurt Libya's ties to the West. The six co-defendants already have served seven years in jail.

Earlier this month, an analysis of HIV and hepatitis virus samples taken from some of the children concluded the viral strains were circulating at the hospital where they were treated well before the nurses and doctor arrived in March 1998, according to research published by the journal Nature.

There is widespread anger in Libya over the HIV infections, and the sentence brought cheers. The Libyan press has long depicted the medical workers as guilty.

Five Bulgarian nurses and a Palestinian doctor could face the firing squad if a Libyan court convicts them on Tuesday on charges of deliberately infecting hundreds of Libyan children with HIV.

Concluding a retrial regarded by the outside world as a test of justice in Libya, the court will make a decision that, either way, is likely to have repercussions on the north Africa's gradual rapprochement with the West.

The six are accused of intentionally infecting 426 Libyan children with HIV at a hospital in Benghazi in the late 1990s. The prosecution has demanded the death penalty.

A new US-funded clinic in downtown Johannesburg is giving hundreds of South African HIV sufferers a first chance to afford anti-retroviral drugs by offering them at a third of the market rate.

For years, patients with the AIDS virus have either had to dole out thousands of dollars a year for anti-retrovirals (ARVs) and accompanying treatment or else try their luck with the groaning public health system.

But now the Zuzimpilo medical centre, based in a rundown building at the heart of Johannesburg's inner city, aims to relieve some of the pressure on both cash-strapped patients and over-stretched hospitals.

Patna, Dec 16 (IANS) In the absence of vaccine against HIV/AIDS, the 'social vaccine' of mass awareness needs to be strengthened to prevent spread of the deadly virus, a top UN official here said Saturday.

"Social vaccine is the main weapon to fight against the HIV/AIDS," said Peter Piot, executive director of United Nations Programme on HIV/AIDS (UNAIDS).

"By social vaccine I mean to create a mass awareness to educate the people about the killer disease and on how to prevent it" said Piot, who was member of a delegation on a daylong visit to Bihar along with Suma Chakrabarti, permanent Secretary, Department for International Development (DFID) of Britain.

The National Alliance of State and Territorial AIDS Directors on Tuesday released the latest ADAP Watch on AIDS Drug Assistance Programs, which are federal- and state-funded programs that provide HIV/AIDS-related medications to low-income, uninsured and underinsured HIV-positive individuals. A synopsis of the report appears below.

The report finds that as of Nov. 15, 340 individuals were on ADAP waiting lists in Alaska, Montana and South Carolina. Four states -- Alabama, Indiana, Oklahoma and South Carolina -- have instituted other cost-containment measures since the beginning of fiscal year 2006, the report says.

HIV/AIDS is costing more than 1 million jobs annually worldwide, with most of those losses in sub-Saharan African, according to a report from the International Labor Organization (ILO).

Containing updated estimates of HIV’s impact on the world of work, the labor force and the working-age population in 60 countries, the report ILO released Nov. 30 also looked at such issues as the effect of AIDS on employment growth.

Among its findings:

Campaigners mixed joy with prudence after new trials, described as a watershed in the quarter-century-long tragedy of AIDS, showed circumcision nearly halves a man's risk of catching HIV.

They hailed it as a golden opportunity Thursday for braking a pandemic that has claimed 25 million lives, left another 40 million infected with HIV and for which there is no cure, only a costly, lifelong dependence on drugs.

Until now, the only prevention strategies have depended on condoms and sexual abstinence, both of which are of only limited effect.

But the campaigners also cautioned that circumcision -- while low-cost, one-off and effective -- was no silver bullet.

Zimbabwe has received a 65 million US dollar grant from the United Nations to bolster its fight against HIV and AIDS, tuberculosis and malaria, a government minister has said.

"We signed the agreement with them (the UN's Global Fund) yesterday," junior health minister Edwin Muguti told AFP Thursday.

"These funds will be used to increase our HIV and AIDS, malaria and tuberculosis programme. We also hope to reintroduce the fixed drug combination of anti-tuberculosis drugs using these funds."

NIGERIA - "AIDS is real, Avoid casual sex," "Abstinence is the best protection against AIDS," "Avoiding AIDS, as easy as... (ABC) Abstain, Be faithful (to your partner) Condom use," "A Hug gives comfort, not HIV/AIDS, Show love and care to people living with HIV/AIDS," "Stop AIDS, Keep the Promise,"... and so the campaign against the spread of the Human Immuno-deficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) on bill boards the world over seem innumerable.

Bill boards are not the only media used to mount the campaign against the spread of the pandemic. News reports, jingles and programmes are aired and televised in the broadcast, and news reports, features, opinions, editorials and advertisements published in the print media against its spread, have permeated the surface of the globe. All these are apart from public awareness rallies.

The campaigns increase and rage broader by the day, seemingly at the same speed with the reported spread of the pandemic, at some instances, seeming at a higher speed, to remoter human settlements, especially in African and Asian countries, most especially in those reportedly having the highest prevalence rate.

The deadline for the “World Awards for Best TV and Radio Programs on HIV and AIDS” has been extended from December 1, 2006, to January 15, 2007 to allow reports broadcast on World Aids Day to be submitted.            

The awards are being sponsored by the Asia-Pacific Institute for Broadcasting Development (AIBD) with UNAIDS and will be presented during its “HIV and AIDS Global Media Strategies” conference in May 2007.

Freelancers and producers from broadcasting organizations with reports that were broadcast between December 1, 2004, and December 1, 2006, are invited to apply.

The Centers for Disease Control and Prevention (CDC) recognizes the faith community’s influence on knowledge, attitudes, beliefs, and behaviors about health. Since 1996, CDC has provided resources to faith-based organizations and worked to make them part of HIV prevention efforts. Faith-based organizations have conducted many HIV prevention activities. These activities include capacity-building assistance and training programs for faith leaders whose communities have high rates of HIV/AIDS.

CDC held a two-day meeting on “Faith and HIV Prevention” on February 13-14, 2006 in Atlanta, GA. The meeting was held to expand and strengthen CDC’s partnerships with faith communities. People who attended the meeting included faith leaders, people who provide HIV services, and public health workers. They discussed the role of faith-based organizations in helping prevent HIV/AIDS. There were 48 people at the meeting, including 29 leaders from many faiths, including Protestant, Catholic, Jewish, Hebrew-Israelite, Muslim, and Buddhism.

The Vice President of Kenya, Dr Moody Awori, has urged the nationwide adoption of a home-based care model co-developed with the UK Christian HIV and AIDS charity Mildmay Mission Hospital.

The appeal follows years of close partnership between Mildmay and the Kenyan Ministry of Health which worked together to form the Nyanza Model of Home-Based Care for HIV and AIDS sufferers in Kenya.

The Nyanza Model’s success has now convinced the government that the whole country – which has a total of 1.3 million HIV and AIDS sufferers - would benefit from adopting this ‘best practice’ model.

JOHANNESBURG - South Africa, which has the world's second heaviest caseload of HIV/Aids, has seen average life expectancy fall by 13 years since 1990 to 51, a new study shows.

A survey by the Medical Research Council and Actuarial Society of South Africa revealed that life expectancy this year was "estimated to be 49 years for males and 53 years for females" or an average of 51.

"By 2005, the HIV/Aids pandemic had already taken about 13 years off life expectancy," the report stated.

Researcher Debbie Bradshaw said life expectancy in South Africa in 1990 was 64 years, but had dropped to 51.

LOS ANGELES, Dec. 11 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation's largest provider of HIV/AIDS healthcare, education and prevention and direct provider of HIV/AIDS medical care to tens of thousands of AIDS patients in the US, Africa, Latin America/Caribbean and Asia, launches a print advertising campaign this week calling on Pfizer, Inc., the world's largest pharmaceutical company, to end its marketing of its erectile dysfunction drug, Viagra, as a sexual enhancement drug, thereby encouraging its recreational use and fueling the spread of sexually transmitted diseases, including HIV.

The first wave of the Viagra + Meth = Rx for HIV Infection ad campaign begins in New York and Los Angeles this week with full-page ads in The Village Voice, The New York Blade and LA Weekly, with an ad appearing next week in L.A.'s Frontiers Magazine. The ads alert the public to the dangers of combining Viagra with crystal methamphetamines (an illegal drug, also know as crystal meth) and urges the pharmaceutical giant "to exercise responsibility by discontinuing marketing to men with mild erectile dysfunction, and by initiating an educational campaign on the dangers of Viagra and crystal meth, targeting men who have sex with men."

As usual, The Washington Post has another brilliant article. this time it is about HIV, and how many employers still lack policies on AIDS prevention and care.

Two weeks after she started to work at Catholic Relief Services in 2004, Jennifer Munthali decided to tell her boss that she was HIV positive.

"I barely knew my supervisor," said Munthali, who was the program manager for AIDS relief in Zambia. "It was indeed a scary time. Even though I was at a higher management level, I was afraid I was going to lose my job."

James Morris, the United Nations special envoy for southern Africa, hailed Malawi for expanding the rollout of anti-retroviral drugs to reach 70,000 AIDS sufferers by the end of this year.

"This is a dramatic increase of 70,000 from 8,000 two years ago... lives have been saved and it's possible to be productive citizens again," Morris, on the second leg of a five-nation visit, told reporters here.

Morris arrived here from Zambia for a two-day visit, the last to the region of his tenure, and will meet government officials, donor representatives, UN agencies and non-governmental organisations.

A Bangladeshi women's group was awarded a cash prize of $20,000 on Monday for its work in preventing the spread of HIV/AIDS, the United Nations Development Program (UNDP) said.

The "Durjoy Nari Shongo" (indomitable women's council) shared the UNDP's "Red Ribbon" 2006 award with four other groups in Ukraine, Thailand, Zimbabwe and Zambia.

The Bangladeshi group distributes condoms, gives information about AIDS to sex workers and provides for the education of their children.

For two years she laboured in the shadow of her boss, South Africa's notorious health minister, who declared garlic, lemon and beetroot a suitable treatment for the country's victims of Aids.

Now Nozizwe Madlala-Routledge, a plain-speaking 55-year-old Quaker, is being feted as a heroine by health campaigners, Aids sufferers and much of South Africa's media, for daring to end a decade of denial on the disease by the ruling African National Congress.

In the space of a few weeks the deputy health minister has helped turn government policy on its head.

AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today joined scores of other global AIDS advocates in praising Thailand's Ministry of Health announcing its intention to issue a compulsory license for the lifesaving HIV/AIDS drug Efavirenz, made by Merck. World Trade Organization regulations include flexibilities, which allow governments to issue compulsory licenses without consulting the foreign patent owner.

"We applaud Thailand's Ministry of Health for courageously issuing this compulsory license to make an affordable version of the AIDS drug Efavirenz," said Michael Weinstein, President of AIDS Healthcare Foundation. "With this one move, Thailand has placed the health of its citizens ahead of drug company profits and now stands with Brazil and Malaysia as a model for countries around the world whose people are in need of lifesaving AIDS medicines. We call on governments in countries where people continue to lack access to urgently-needed AIDS drugs to follow Thailand's lead and pursue all tactics necessary to provide their citizens with lifesaving medicines."

source - Phama Lexicon 

HealthDay News -- Within a few weeks of being infected by HIV, most of a person's memory T-cells vanish and are not likely to return even after years of antiretroviral treatment, a new study finds.

Previous research has shown that HIV infection depletes memory T-cells -- which are mostly found in the intestinal tract -- within days. In contrast, T-cells circulating in the blood typically decline over several years, according to background information in the article.

It's known that T-cells in the blood can return to normal levels when HIV patients take antiviral drugs. But it wasn't clear whether intestinal memory T -cell levels returned to normal.

In this study, researchers at the Aaron Diamond AIDS Research Center in New York City and elsewhere performed intestinal biopsies on HIV patients who had started treatment shortly after they were infected.

Using hormonal contraception does not appear to increase women's overall risk of contracting the AIDS virus, according to a U.S. National Institutes of Health study published on Thursday.

The study, published on the Web site of the journal "AIDS," followed thousands of women in Africa and Asia and compared their patterns of contraceptive use to their risk of infection with HIV, the virus that causes AIDS.

"Understanding whether hormonal contraceptive use alters the risk of HIV acquisition among women is a critical public health issue," the study authors wrote.

Some 6,000 women, in Uganda, Zimbabwe and Thailand enrolled in the study were offered a choice of the most commonly prescribed forms of hormonal contraception, birth control pills or DMPA (depot-medroxyprogesterone acetate) injections, as well as condoms.

RIYADH, 6 December 2006 — The pale young man suddenly got up from his chair, walked to the stage, and began his presentation.

“I stand before you today as perhaps the longest living person infected with AIDS in Saudi Arabia,” said the 30-year-old Makkawi at an AIDS symposium organized yesterday by the National Society for Human Rights at the King Faisal Specialist Hospital and Research Center here.

“My name is Rami ibn Faisal Al-Harithi Al-Shareef. I was infected with HIV when I was six years old when my mom took me to get circumcised,” he said.

Malaria is fueling the spread of AIDS in Africa by boosting the HIV in people's bodies for weeks at a time, says a study that pins down the deadly interplay between the dual scourges.

It's a vicious cycle as people weakened by HIV are, in turn, more vulnerable to malaria.

University of Washington researchers who estimated the impact of the overlapping infections concluded that the interaction could be blamed for thousands of HIV infections and almost a million bouts of malaria over two decades in just one part of Kenya.

The research, published in Friday's edition of the journal Science, highlights the need for a joint attack on both epidemics.

The fight against the spread of HIV and AIDS in the country got a boost on Thursday with a 49-million-dollar Global Fund support to three agencies to combat the scourge of the disease.

The three agencies are the National Action Committee Against HIV/AIDS (NACA), Society for Family Health (SFH) and the Association for Reproductive and Family Health (ARFH).

The agencies jointly signed the agreement with Global Fund at the reception organised for the visiting delegation of the Fund at the Ocean View Restaurant, Victoria Island Lagos.

University of Utah scientists designed a "molecular condom" women could use daily to prevent AIDS by vaginally inserting a liquid that would turn into a gel-like coating and then, when exposed to semen, return to liquid form and release an antiviral drug.

"We have developed a new vaginal gel that we call a molecular condom because it is composed of molecules that are liquid at room temperature and, when applied in the vagina, will spread and turn into a gel and effectively coat the tissue," says Patrick Kiser, an assistant professor of bioengineering. "It's a smart molecular condom because we designed this gel to release anti-HIV drugs when the gel comes into contact with semen during intercourse."

"The ultimate hope for this technology is to protect women and their unborn or nursing children from the AIDS virus," but the molecular condom is five years away from tests in humans and roughly 10 years until it might be in widespread use, Kiser says.

International diabetes experts warn that one of South Africa's most commonly used anti-Aids drugs could, in the long term, send the country's diabetes rates spiralling.

The concern has prompted a local HIV and Aids expert, who referred to the drug as "the villain" among first-line treatment, to call on pharmaceutical companies to make alternatives more affordable.

Dutch diabetes expert Professor Peter Reiss raised the alarm on the second day of the World Diabetes Congress currently on in the city.

But he warned that the toxicity of d4T should not be used as an argument for withholding lifesaving treatment.

by Iris Phillips, 100 mile Free Press, Canada

Dec. 1, was World AIDS Day but somehow I missed hearing about it or if I did I just didn’t pay attention.

I did spend a bit of time tracking the happenings of the Liberal Leadership Convention. Somehow it’s like watching the history of our country unfold right before our eyes. Fascinating stuff.

So somehow World AIDS Day just passed me by.

And to be honest, does it really matter?

You never hear much abo